CoChat

Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity

Open access
WEBB, Michael R., EBELER, Susan E. · 2004 · Biochemical Journal
Cited by 145

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Flavonoids and other polyphenolic compounds have been shown to inhibit human topoisomerase IB (topo I) through both inhibition of relaxation activity and through stabilization of the cleavable complex (poisoning). Some flavonoids have also been shown to intercalate DNA, and an association of topoisomerase inhibition with intercalation has been noted. We surveyed 34 polyphenolic compounds, primarily flavonoid glycones and aglycones, for their ability to inhibit topo I and to intercalate DNA using an in vitro gel electrophoresis method. We show that the most potent topo I poisons are the flavones and flavonols, and that these generally, but not always, are found to be DNA intercalators. There was no clear correlation, however, of topo-I-poisoning activity with the degree of DNA unwinding. Surprisingly, both DNA intercalation and topo I poisoning were shown to occur with some flavone glycones, including the C-glycosylflavone orientin. Inhibition of relaxation activity by flavonoids was found to be difficult to quantify and was most likely to be due to non-specific inhibition through flavonoid aggregation. As part of a structure–activity analysis, we also investigated the acid–base chemistry of flavonoids and determined that many flavonoids show acid–base activity with a pKa in the physiological pH region. For this reason, subtle pH changes can have significant effects on solution activity of flavonoids and their concomitant biological activity. In addition, these effects may be complicated by pH-dependent aggregation and oxidative degradation. Finally, we develop a simple model for the intercalation of flavonoids into DNA and discuss possible consequences of intercalation and topoisomerase inhibition on a number of cellular processes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bj20040474

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 42

  1. Formica, 1995, Review of the biology of quercetin and related bioflavonoids, Food Chem. Toxicol., 33, 1061, 10.1016/0278-6915(95)00077-1 · DOI · Paper page
  2. Nijveldt, 2001, Flavonoids: a review of probable mechanisms of action and potential applications, Am. J. Clin. Nutr., 74, 418, 10.1093/ajcn/74.4.418 · DOI · Paper page
  3. Ferguson, 2001, Role of plant polyphenols in genomic stability, Mutat. Res., 475, 89, 10.1016/S0027-5107(01)00073-2 · DOI · Paper page
  4. Le Marchand, 2002, Cancer preventive effects of flavonoids – a review, Biomed. Pharmacother., 56, 296, 10.1016/S0753-3322(02)00186-5 · DOI · Paper page
  5. Manach, 1996, Bioavailability, metabolism, and physiological impact of 4-oxo-flavonoids, Nutr. Res., 16, 517, 10.1016/0271-5317(96)00032-2 · DOI · Paper page
  6. Galati, 2002, Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics, Toxicology, 177, 91, 10.1016/S0300-483X(02)00198-1 · DOI · Paper page
  7. Boege, 1996, Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I, J. Biol. Chem., 271, 2262, 10.1074/jbc.271.4.2262 · DOI · Paper page
  8. Yamashita, 1990, Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol, Biochem. Pharmacol., 39, 737, 10.1016/0006-2952(90)90153-C · DOI · Paper page
  9. Wang, 2002, Cellular roles of DNA topoisomerases: a molecular perspective, Nat. Rev. Mol. Cell Biol., 3, 430, 10.1038/nrm831 · DOI · Paper page
  10. Trask, 1988, Stabilization of type I topoisomerase–DNA covalent complexes by actinomycin D, Proc. Natl. Acad. Sci. U.S.A., 85, 1417, 10.1073/pnas.85.5.1417 · DOI · Paper page
  11. Lehmann, 2003, Doxorubicin and two of its analogues are preferential inducers of homologous recombination compared with mutational events in somatic cells of Drosophila melanogaster, Mutat. Res., 539, 167, 10.1016/S1383-5718(03)00162-1 · DOI
  12. Sabourin, 2003, Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks, Nucleic Acids Res., 31, 4373, 10.1093/nar/gkg497 · DOI
  13. Wu, 2003, The Bloom's syndrome helicase suppresses crossing over during homologous recombination, Nature (London), 426, 870, 10.1038/nature02253 · DOI · Paper page
  14. Strick, 2000, Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia, Proc. Natl. Acad. Sci. U.S.A., 97, 4790, 10.1073/pnas.070061297 · DOI · Paper page
  15. Peterson, 2003, Flavonoid intake and breast cancer risk: a case-control study in Greece, Br. J. Cancer, 89, 1255, 10.1038/sj.bjc.6601271 · DOI · Paper page
  16. Constantinou, 1995, Flavonoids as DNA topoisomerase antogonists and poisons – structure–activity-relationships, J. Nat. Prod., 58, 217, 10.1021/np50116a009 · DOI · Paper page
  17. Webb, 2003, A gel electrophoresis assay for the simultaneous determination of topoisomerase I inhibition and DNA intercalation, Anal. Biochem., 321, 22, 10.1016/S0003-2697(03)00459-7 · DOI
  18. Sober, 1968, Buffer solutions
  19. Hertzberg, 1989, On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme–DNA complex, Biochemistry, 28, 4629, 10.1021/bi00437a018 · DOI · Paper page
  20. McGovern, 2002, A specific mechanism of nonspecific inhibition, J. Med. Chem., 45, 1712, 10.1021/jm010533y · DOI · Paper page
  21. Jovanovic, 1994, Flavonoids as antioxidants, J. Am. Chem. Soc., 116, 4846, 10.1021/ja00090a032 · DOI · Paper page
  22. Wagner, 1976, 13C-NMR-spektren natuerlich vorkommender flavonoide, Tetrahedron Lett., 21, 1799, 10.1016/S0040-4039(00)93787-0 · doi:10.1016/s0040-4039(00)93787-0
  23. Dangles, 2001, Binding of flavonoids to plasma proteins, Methods Enzymol., 335, 319, 10.1016/S0076-6879(01)35254-0 · DOI
  24. Mocek, 1972, Kinetics and mechanism of quercetin oxidation, J. Inst. Brew., 78, 459, 10.1002/j.2050-0416.1972.tb03481.x · doi:10.1002/j.2050-0416.1972.tb03481.x
  25. Bailly, 1999, Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents, Cancer Res., 59, 2853
  26. Snyder, 2002, Evaluation of the clastogenic, DNA intercalative and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells, Environ. Mol. Mutagen., 40, 266, 10.1002/em.10121 · DOI · Paper page
  27. Rueff, 1986, Genetic toxicology of flavonoids: the role of metabolic conditions in the induction of reverse mutation, SOS functions and sister-chromatid exchanges, Mutagenesis, 1, 179, 10.1093/mutage/1.3.179 · DOI
  28. Popp, 1991, Induction of sister-chromatid exchanges (SCE), polyploidy, and micronuclei by plant flavonoids in human lymphocyte cultures: a comparative study of 19 flavonoids, Mutat. Res., 246, 205, 10.1016/0027-5107(91)90123-6 · DOI
  29. Pilch, 1997, Minor groove-directed and intercalative ligand–DNA interactions in the poisoning of human DNA topoisomerase I by protoberberine analogs, Biochemistry, 36, 12542, 10.1021/bi971272q · doi:10.1021/bi971272q
  30. Burda, 2001, Antioxidant and antiradical activities of flavonoids, J. Agric. Food Chem., 49, 2774, 10.1021/jf001413m · DOI · Paper page
  31. Wilson, 1999, DNA intercalators, 427, 10.1016/B978-0-08-091283-7.00067-9 · DOI
  32. Austin, 1992, Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives, Biochem. J., 282, 883, 10.1042/bj2820883 · DOI · Paper page
  33. Harmon, 1999, RecQ helicase and topoisomerase III comprise a novel DNA strand passage function: a conserved mechanism for control of DNA recombination, Mol. Cell, 3, 611, 10.1016/S1097-2765(00)80354-8 · DOI
  34. Silva, 2000, Chemical features of flavonols affecting their genotoxicity: potential implications in their use as therapeutical agents, Chem. Biol. Interact., 124, 29, 10.1016/S0009-2797(99)00139-8 · DOI
  35. Uhl, 2003, Effect of chrysin, a flavonoid compound, on the mutagenic activity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and benzo(a)pyrene (B(a)P) in bacterial and human hepatoma (HepG2) cells, Arch. Toxicol., 77, 477, 10.1007/s00204-003-0469-4 · doi:10.1007/s00204-003-0469-4
  36. Edenharder, 2003, Inhibition of clastogenicity of benzo[a]pyrene and of its trans-7,8-dihydrodiol in mice in vivo by fruits, vegetables, and flavonoids, Mutat. Res., 537, 169, 10.1016/S1383-5718(03)00078-0 · DOI
  37. Ebeler, 2002, Dietary catechin delays tumor onset in a transgenic mouse model, Am. J. Clin. Nutr., 76, 865, 10.1093/ajcn/76.4.865 · DOI
  38. Kuntz, 1999, Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines, Eur. J. Nutr., 38, 133, 10.1007/s003940050054 · DOI · Paper page
  39. Wang, 1999, Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukemia HL-60 cells, Eur. J. Cancer., 35, 1517, 10.1016/S0959-8049(99)00168-9 · DOI · Paper page
  40. Calabrese, 1998, Can the concept of hormesis be generalized to carcinogenesis?, Regul. Toxicol. Pharmacol., 28, 230, 10.1006/rtph.1998.1267 · doi:10.1006/rtph.1998.1267
  41. Soe, 2003, p53 stimulates human topoisomerase I activity by modulating its DNA binding, Nucleic Acids Res., 31, 6585, 10.1093/nar/gkg846 · doi:10.1093/nar/gkg846
  42. Laine, 2003, Werner protein stimulates topoisomerase I DNA relaxation activity, Cancer Res., 63, 7136

Cited by

Metadata

Authors
WEBB, M. R., & EBELER, S. E.
Venue
Biochemical Journal
Published
2004-12-07
Volume
384
Issue
3
Pages
527-541
ISSN
  • 0264-6021 (ISSN-L)
  • 1470-8728
OpenAlex
W1967936457
Cited by
145
References
5
FWCI
1.53
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.